Naviten - analogs
Components: Eprosartan |
|||||||||
Pharmgroups: Angiotensin II receptor antagonists (AT1 subtype) |
|||||||||
| Prices in pharmacies: — Instructions Naviten | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Nicergoline ✘ (incl) Hydrochlorothiazide ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Negative 🔍 Teveten | 22.7€ |
| ≈100% | Negative 🔍 Eprosartan sodium | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 30% 38.2€ Rasilez neutral [Aliskiren]
- 30% — Isobar neutral [Triamterene]
- 30% — RILMENIDINE neutral
- 29% 18.5-22.9€ Teveten Plus Dangerous 🔍 [Hydrochlorothiazide+Eprosartan and more 2Hydrochlorothiazide, Eprosartan]
- 28% 5.6-12.9€ Edarbi Negative 🔍 [Azilsartan medoxomil]
- 28% 0.3-3.5€ Moxonidine Negative 🔍 [Moxonidine]
- 28% 2.4-9.4€ Physiotens Negative 🔍 [Moxonidine]
- 28% 0.8-4€ Моксонидин Канон Negative 🔍 [Moxonidine]
- 28% 5.3€ Cardosal 10 Negative 🔍 [Olmesartan medoxomil]
- 28% 6.8-8.2€ Cardosal 20 Negative 🔍 [Olmesartan medoxomil]
- 28% 1.9-3.7€ Moxonitex Negative 🔍 [Moxonidine]
- 28% 1.1-3€ Моксонидин-Акрихин Negative 🔍 [Moxonidine]
- 28% 7.6-10.8€ Albarel Negative 🔍 [Rilmenidine]
- 28% — Моксонидин-алиум Negative 🔍 [Moxonidine]
- 28% 0.9-7.1€ Моксарел Negative 🔍 [Moxonidine]
- 28% 4.2-6.1€ Моксонидин Реневал Negative 🔍 [Moxonidine]
- 28% 7.1-8.9€ Cardosal 40 Negative 🔍 [Olmesartan medoxomil]
- 28% — Olmesartan medoxomil Negative 🔍 [Olmesartan medoxomil]
- 28% 2.2-5.8€ Моксонидин авексима Negative 🔍 [Moxonidine]
- 28% 1.4-3.8€ Моксонидин-АЛСИ Negative 🔍 [Moxonidine]
- 28% — Моксонидин Гексал Negative 🔍 [Moxonidine]
- 28% — Moxogamma Negative 🔍 [Moxonidine]
- 28% 2.7-6.9€ Tenzotran Negative 🔍 [Moxonidine]
- 28% 7.9€ Cardosal Negative 🔍 [Olmesartan medoxomil]
- 28% — Фимасартана калия тригидрат Negative 🔍 [Fimasartan]
- 28% 13.9€ Kanarb Negative 🔍 [Fimasartan]
- 28% — Cynt Negative 🔍 [Moxonidine]
- 28% — Olmestra Negative 🔍 [Olmesartan medoxomil]
- 28% — Moex Negative 🔍 [Moexipril]
- 28% 1-5.8€ Moxonidine-SZ Negative 🔍 [Moxonidine]
- 28% 1.3-2.7€ Моксонидин-ЛФ Negative 🔍 [Moxonidine]
- 25% — Lomir Dangerous 🔍 [Isradipine]
- 25% — Sakure Dangerous 🔍 [Lacidipine]
- 25% 2.3-5€ Lernicor Dangerous 🔍 [Lercanidipine]
- 25% — Estulic Dangerous 🔍 [Guanfacine]
- 25% — Lacidipine Dangerous 🔍 [Lacidipine]
- 25% 6.1-11.2€ Lerkamen 20 Dangerous 🔍 [Lercanidipine]
- 25% 2.7-11.1€ Zanidip-Recordati Dangerous 🔍 [Lercanidipine]
- 25% 5.7-13.6€ Lerkamen Dangerous 🔍 [Lercanidipine]
- 25% — Lomir SRO Dangerous 🔍 [Isradipine]
- 25% 3.6-8.5€ Lerkamen 10 Dangerous 🔍 [Lercanidipine]
- 21% 4.3-6.1€ Irbesartan Negative 🔍 [Irbesartan]
- 21% 3.4€ Irsar Negative 🔍 [Irbesartan]
- 21% 4.9€ Ирбис Negative 🔍 [Irbesartan]
- 21% 0.4-1.1€ Raunatine Negative 🔍 [Rauwolfia alkaloids]
- 21% 2.6-4.4€ Irbesartan Canon Negative 🔍 [Irbesartan]
- 20% — Lacipil Dangerous 🔍 [Lacidipine]
- 20% — Метилдопы сесквигидрат Dangerous 🔍 [Methyldopa]
- 20% 5.3-6.7€ Nebilong AM Dangerous 🔍 [Amlodipine+Nebivolol and more 2Amlodipine, Nebivolol]
- 20% 3.2-4.7€ Лерканидипин-СЗ Dangerous 🔍 [Lercanidipine]
Learn more about the selection of analogues
- The drug has «Naviten» 2 full analogs, the cheapest - Teveten (22.7€); 51 analog by action, the most similar - Rasilez (38.2€).
- Medical online service has selected the best substitutes for Naviten based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Naviten to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.